JP2012107046A5 - - Google Patents

Download PDF

Info

Publication number
JP2012107046A5
JP2012107046A5 JP2012035170A JP2012035170A JP2012107046A5 JP 2012107046 A5 JP2012107046 A5 JP 2012107046A5 JP 2012035170 A JP2012035170 A JP 2012035170A JP 2012035170 A JP2012035170 A JP 2012035170A JP 2012107046 A5 JP2012107046 A5 JP 2012107046A5
Authority
JP
Japan
Prior art keywords
olopatadine
polyvinylpyrrolidone
solution composition
composition
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012035170A
Other languages
English (en)
Japanese (ja)
Other versions
JP5328947B2 (ja
JP2012107046A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2012107046A publication Critical patent/JP2012107046A/ja
Publication of JP2012107046A5 publication Critical patent/JP2012107046A5/ja
Application granted granted Critical
Publication of JP5328947B2 publication Critical patent/JP5328947B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2012035170A 2001-06-27 2012-02-21 局所投与のためのオロパタジン処方物 Expired - Lifetime JP5328947B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30131501P 2001-06-27 2001-06-27
US60/301,315 2001-06-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010069010A Division JP2010150292A (ja) 2001-06-27 2010-03-24 局所投与のためのオロパタジン処方物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013061887A Division JP2013127005A (ja) 2001-06-27 2013-03-25 局所投与のためのオロパタジン処方物

Publications (3)

Publication Number Publication Date
JP2012107046A JP2012107046A (ja) 2012-06-07
JP2012107046A5 true JP2012107046A5 (enExample) 2013-05-09
JP5328947B2 JP5328947B2 (ja) 2013-10-30

Family

ID=23162841

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2003508332A Expired - Lifetime JP4827374B2 (ja) 2001-06-27 2002-06-19 局所投与のためのオロパタジン処方物
JP2009048628A Withdrawn JP2009114213A (ja) 2001-06-27 2009-03-02 局所投与のためのオロパタジン処方物
JP2010069010A Withdrawn JP2010150292A (ja) 2001-06-27 2010-03-24 局所投与のためのオロパタジン処方物
JP2012035170A Expired - Lifetime JP5328947B2 (ja) 2001-06-27 2012-02-21 局所投与のためのオロパタジン処方物
JP2013061887A Withdrawn JP2013127005A (ja) 2001-06-27 2013-03-25 局所投与のためのオロパタジン処方物

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2003508332A Expired - Lifetime JP4827374B2 (ja) 2001-06-27 2002-06-19 局所投与のためのオロパタジン処方物
JP2009048628A Withdrawn JP2009114213A (ja) 2001-06-27 2009-03-02 局所投与のためのオロパタジン処方物
JP2010069010A Withdrawn JP2010150292A (ja) 2001-06-27 2010-03-24 局所投与のためのオロパタジン処方物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013061887A Withdrawn JP2013127005A (ja) 2001-06-27 2013-03-25 局所投与のためのオロパタジン処方物

Country Status (20)

Country Link
US (2) US6995186B2 (enExample)
EP (1) EP1399127B1 (enExample)
JP (5) JP4827374B2 (enExample)
KR (1) KR100884711B1 (enExample)
CN (1) CN1211125C (enExample)
AR (1) AR034619A1 (enExample)
AT (1) ATE295149T1 (enExample)
AU (1) AU2002310461B2 (enExample)
BR (1) BRPI0210707B8 (enExample)
CA (1) CA2447924C (enExample)
DE (1) DE60204142T2 (enExample)
DK (1) DK1399127T3 (enExample)
ES (1) ES2238574T3 (enExample)
GC (1) GC0000397A (enExample)
MX (1) MXPA03011947A (enExample)
PL (1) PL205565B1 (enExample)
PT (1) PT1399127E (enExample)
TW (1) TWI231759B (enExample)
WO (1) WO2003002093A1 (enExample)
ZA (1) ZA200308771B (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100055152A1 (en) * 2008-08-26 2010-03-04 Trutek Corporation Antihistamine and antihistamine-like nasal application, products, and method
US7977376B2 (en) * 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
US20050209312A1 (en) * 2004-03-19 2005-09-22 Bausch & Lomb Incorporated Carboxylic acid derivatives of doxepin formulations preserved with low-irritation preservative
US20070275853A1 (en) * 2004-04-08 2007-11-29 Kyowa Hakko Kogyo Co., Ltd. Solid Products with Improved Stability and Method for Producing the Same
WO2005102313A1 (ja) * 2004-04-21 2005-11-03 Kyowa Hakko Kogyo Co., Ltd. 慢性副鼻腔炎の予防および/または治療剤
KR20070024618A (ko) * 2004-06-28 2007-03-02 알콘, 인코퍼레이티드 알레르기성 질환 치료용 국소 제제
CN101065122A (zh) * 2004-11-24 2007-10-31 爱尔康公司 输送鼻孔喷雾剂的方法
WO2006097458A1 (en) * 2005-03-15 2006-09-21 Nycomed Gmbh Novel combination
EP1901708B1 (en) 2005-07-08 2013-09-11 Senju Pharmaceutical Co., Ltd. Percutaneously absorptive ophthalmic preparation comprising olopatadine
US20070077302A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for stabilizing ophthalmic compositions
US20080114076A1 (en) * 2006-11-09 2008-05-15 Alcon Manufacturing Ltd. Punctal plug comprising a water-insoluble polymeric matrix
TWI409081B (zh) 2006-11-09 2013-09-21 Alcon Res Ltd 用於藥物輸送之水不溶性聚合物基質
AU2007334248B2 (en) * 2006-12-18 2013-06-27 Alcon Research, Ltd. Devices and methods for ophthalmic drug delivery
WO2008093358A2 (en) * 2007-01-29 2008-08-07 Sun Pharmaceutical Industries Limited Aqueous topical solution containing olopatadine
KR20100014858A (ko) * 2007-02-07 2010-02-11 알콘, 인코퍼레이티드 국소 비강 투여용 올로파타딘 제제
WO2008120249A1 (en) * 2007-03-30 2008-10-09 Sifi S.P.A. Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use
UY31017A1 (es) * 2007-04-11 2008-07-03 Alcon Res Ltd Uso de un inhibidor del factor &(alfa) de necrosis tumoral mas un antihistaminico para el tratamiento de la rinitis alérgica y la conjuntivitis alérgica.
EP2189157A4 (en) * 2007-09-06 2012-10-31 Kyowa Hakko Kirin Co Ltd EYE DROPPING WITH DIBENZO [b, e] OXEPINE DERIVATIVE
CN102026665A (zh) * 2008-05-19 2011-04-20 爱尔康研究有限公司 含有羧基乙烯基聚合物和聚维酮聚合物的药物组合物
CN102089039B (zh) * 2008-08-26 2013-10-23 博磊科技股份有限公司 带静电荷口罩过滤产品和用于增加过滤效率的方法
JP2012509250A (ja) * 2008-08-28 2012-04-19 トルテック コーポレーション 抗ヒスタミン及び抗ヒスタミン様経鼻適用製品及び方法
US9458198B1 (en) 2009-06-26 2016-10-04 Shire Orphan Therapies Gmbh Cyclic peptide-based NPR-B agonists
EP2453872B1 (en) * 2009-07-17 2013-08-21 Alcon Research, Ltd. Olopatadine nasal spray regimen for children
WO2011027322A1 (en) * 2009-09-03 2011-03-10 Ranbaxy Laboratories Limited Extended release dosage form containing olopatadine for oral administration
WO2011038066A2 (en) * 2009-09-25 2011-03-31 Alcon Research, Ltd. Novel npr-b agonists
JP5893561B2 (ja) 2009-09-25 2016-03-23 シャイア・オーファン・セラピーズ・ゲーエムベーハーShire Orphan Therapies GmbH 新規npr−bアゴニスト
KR20120091037A (ko) * 2009-10-01 2012-08-17 알콘 리서치, 리미티드 올로파타딘 조성물 및 그의 용도
AR078446A1 (es) 2009-12-18 2011-11-09 Alcon Res Ltd Agonistas de npr-b. uso.
WO2011075471A2 (en) 2009-12-18 2011-06-23 Alcon Research, Ltd. Novel npr-b agonists and methods of use for the treatment of c-type natriuretic peptide-mediated disorders
JP2013535451A (ja) * 2010-07-21 2013-09-12 アルコン リサーチ, リミテッド 増強された溶解度特徴を有する薬学的組成物
US20120264681A1 (en) * 2010-11-08 2012-10-18 Healor Ltd. Buffered ophthalmic compositions and methods of use thereof
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠(olopatadine)眼用組成物
CN102885767A (zh) * 2012-11-02 2013-01-23 江苏吉贝尔药业有限公司 一种新的盐酸奥洛他定滴眼液及其制备方法
MA47418A (fr) 2017-02-01 2021-06-02 Takeda Pharmaceuticals Co Composés et compositions pour le traitement de troubles ophtalmiques
WO2018235935A1 (ja) * 2017-06-23 2018-12-27 参天製薬株式会社 水溶性粘稠化剤を含有する医薬組成物
JP7037349B2 (ja) * 2017-06-23 2022-03-16 参天製薬株式会社 水溶性粘稠化剤を含有する医薬組成物
EP4070792A4 (en) * 2019-12-06 2023-11-15 Toko Yakuhin Kogyo Co., Ltd. RHINE CHYSIS COMPOSITION WITH OLOPATADINE
US20230145529A1 (en) * 2020-03-31 2023-05-11 Santen Pharmaceutical Co., Ltd. Silver salt-containing ophthalmic aqueous composition filled in resin container
CN111700860A (zh) * 2020-07-09 2020-09-25 浙江尖峰药业有限公司 盐酸奥洛他定滴眼液及其制备方法
CN119318630B (zh) * 2024-10-16 2025-08-22 苏州欧康维视生物科技有限公司 一种阿托品药物组合物

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370324A (en) 1980-09-17 1983-01-25 Bernstein Joel E Method and composition for treating and preventing irritation of the eyes
US4407791A (en) * 1981-09-28 1983-10-04 Alcon Laboratories, Inc. Ophthalmic solutions
US4749700A (en) 1984-10-23 1988-06-07 Nastech Pharmaceutical Co, Inc. Novel methods of administering antihistamines, antinausea and antiemetic pharmaceutical agents and novel dosage forms containing same
US4923892A (en) 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
GB8520662D0 (en) 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
EP0316633B1 (de) 1987-11-13 1993-01-27 ASTA Medica Aktiengesellschaft Azelastin enthaltende Arzneimittel zur Anwendung in der Nase und/oder am Auge
IT1250691B (it) 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
JP3662944B2 (ja) 1993-08-24 2005-06-22 協和醗酵工業株式会社 点鼻剤
US5897858A (en) 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
US5641805A (en) 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
EP1014979A4 (en) 1997-06-09 2003-08-20 Bridge Pharma Inc CONNECTIONS WITH COMBINED ANTIHISTAMINIC AND FAST-CELL STABILIZING ACTIVITY FOR OPHTHALMOLOGICAL USE
WO2000003705A1 (en) 1998-07-14 2000-01-27 Alcon Laboratories, Inc. Use of 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid for the manufacture of a medicament for treating non-allergic ophthalmic inflammatory disorders and for the prevention of ocular neovascularization
US6146622A (en) * 1998-10-27 2000-11-14 Alcon Laboratories, Inc. Use of certain anionic amino acid based surfactants to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions
ATE229324T1 (de) * 1998-10-27 2002-12-15 Alcon Lab Inc Konservierungsmittel für lokale pharmazeutische zubereitungen enthaltend eine fettsäure/aminosäure enthaltende seife
US6274626B1 (en) * 1998-12-22 2001-08-14 Bausch & Lomb Incorporated Pheniramine-containing compositions and method for treating allergic responses
US6174914B1 (en) 1999-06-15 2001-01-16 Alcon Laboratories, Inc. Method of inhibiting cytokine release from human ocular cells
AU7363700A (en) 1999-09-21 2001-04-24 Alcon Laboratories, Inc. Use of fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topical pharmaceutical compositions
CA2380532A1 (en) 1999-11-18 2001-05-25 Alcon, Inc. Use of h1 antagonist and a safe steroid to treat eye conditions
EP1250133B1 (en) * 2000-01-25 2005-03-30 Alcon Inc. Ophthalmic anti-allergy compositions suitable for use with contact lenses
AR031135A1 (es) 2000-10-10 2003-09-10 Upjohn Co Composiciones de antibiotico topico para el tratamiento de infecciones oculares
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
PL376970A1 (pl) 2002-11-12 2006-01-23 Alcon, Inc. Zastosowanie środka przeciwalergicznego i steroidu do leczenia alergicznego nieżytu nosa

Similar Documents

Publication Publication Date Title
JP2012107046A5 (enExample)
JP2010150292A5 (enExample)
JP2015500794A5 (enExample)
AR118582A2 (es) Procedimiento para producir sílice precipitada tratada
JP2004536096A5 (enExample)
MX2015009037A (es) Enjuague nasal con miel.
MX354456B (es) Silicato de zirconio microporoso para el tratamiento de hipercalemia.
WO2019023564A8 (en) High concentration anti-c5 antibody formulations
ES3053035T3 (en) Microporous zirconium silicate for treating hyperkalemia
RU2013150861A (ru) Фармацевтическая композиция, содержащая производные глутаримидов, и их применение для лечения эозинофильных заболеваний
JP2012532115A5 (enExample)
EA201990616A3 (ru) Дендримероподобные аминоамиды, обладающие активностью блокаторов натриевых каналов, для лечения сухости глаз и других заболеваний слизистых оболочек
NZ607580A (en) N-heteroaryl compounds
EP4249431A3 (en) Compositions and methods for treating diseases or disorders using extended release nitric oxide releasing solutions
RU2012103458A (ru) Композиции, включающие финафлоксации, и способы лечения офтальмологических, ушных или назальных инфекций
JP2019142974A5 (enExample)
AR082049A1 (es) Formulaciones liquidas de rupatadina fumarato
UA114304C2 (uk) Спосіб зниження сироваткових рівнів сечової кислоти у людини
EA201690854A1 (ru) Фармацевтические композиции с гидратирующим и смазывающим действием
JP2013534527A5 (enExample)
RU2009122281A (ru) Средство для лечения заболеваний в ветеринарии на основе соли фосфония
JP2013529632A5 (enExample)
RU2010141793A (ru) Терапевтические замещенные циклопентаны
GEP20186863B (en) Pharmaceutical composition for use in increasing the trophism of nasal mucosa
JP2016512819A5 (enExample)